Found 0 matching trials
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL PHASE3 With this protocol the ALL-SCT BFM international study group wants
* to ev...
Show More Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Learn More & Join Trial
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment PHASE2 The purpose of the study is to demonstrate clinical efficacy of the investi...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer PHASE2 This is a phase II Randomized comparison clinical trial of activated CIK ar...
Show More Location
Biological treatment center in Fuda cancer hospital
Learn More & Join Trial
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer EARLY_PHASE1 10 participants are expected to be enrolled for this open,Single-armed clin...
Show More Location
Shanghai Tenth People's Hospital
Learn More & Join Trial
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer PHASE2 This is a phase II Randomized comparison clinical trial of activated CIK ar...
Show More Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Learn More & Join Trial
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) PHASE3 The purpose of this study is to evaluate the efficacy and safety of tebenta...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia PHASE3 This phase III trial studies how well blinatumomab works in combination wit...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies combination chemotherapy with blina...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients N/A This is an open-label, intermediate-size patient population expanded access...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma PHASE1 IMCgp100-102 is a Phase I/II study of the weekly intra-patient escalation d...
Show More Location
University California, San Diego Moores Cancer Center
Learn More & Join Trial